Suppression of occurrence and advancement of β-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib

Japanese Journal of Cancer Research

Volumn 92, Issue 6, 2001, Pages 617-623

  Yamada, Y ^a   Yoshimi, N ^a   Hirose, Y ^a   Hara, A ^a   Shimizu, M ^a   Kuno, T ^a   Katayama, M ^a   Qiao, Z ^a   Mori, H ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Celecoxib; Chemoprevention; Colon carcinogenesis; Premalignant lesion; Rat

Indexed keywords

AZOXYMETHANE; BETA CATENIN; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; SILVER;

ANIMAL FOOD; ARTICLE; CANCER STAGING; CELL PROLIFERATION; CHROMOSOME NOR; COLON CANCER; COLON CARCINOGENESIS; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; DRUG TARGETING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING; TUMOR GROWTH;

EID: 0034929024     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01139.x     Document Type: Article

References (31)

1. Aspirin use and reduced risk of fatal colon cancer
2. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
3. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent
4. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds
5. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
6. Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane
7. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
8. Genetic alterations during colorectal-tumor development
9. APC mutations occur early during colorectal tumorigenesis
10. The adenomatous polyposis coli (APC) tumor suppressor
11. Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors
12. Beta-catenin is a target for the ubiquitin-proteasome pathway
13. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
14. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos
15. Functional interaction of beta-catenin with the transcription factor LEF-1
16. Identification of c-MYC as a target of the APC pathway
17. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
18. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis
19. Sequential analysis of morphological and biological properties of β-catenin-accumulated crypts, provable preneoplastic lesions independent of aberrant crypt foci in rat colon carcinogenesis
20. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings
21. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis
22. Nucleolar organizer regions in hepatocarcinogenesis induced by N-2-fluorenylacetamide in rats: Comparison with bromodeoxyuridine immunohistochemistry
23. High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat
24. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats
25. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer
26. Effect of retinoids on AOM-induced colon cancer in rats: Modulation of cell proliferation, apoptosis and aberrant crypt foci
27. Enhancement of experimental colon cancer by genistein
28. Kinetic basis for selective inhibition of cyclo-oxygenases
29. Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells
30. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
31. Regional chemoprevention of carcinogen-induced tumors in rat colon